Loading stock analysis…
Evidence Synthesis
Last synthesized: 20 Oct 2026, 09:47
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
ROSELABS experienced a standard shift on 2026-10-20.
The company's gross margin accelerated to .99%, up from -17.03%. This acceleration is part of a broader trend, as the company's marginal operating leverage also accelerated to .03%, up from -26.08%. Daily trading activity increased, with the company's daily volume rising to 2,748 shares, up from 800 shares previously. Additionally, the close price accelerated to 20.88 INR, up from 19.9 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 0.99 % | -17.03 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -17.03 % | -26.08 | ▲ |
| PRICE_CHANGE_PERCENT | 4.925 % | — | - |
| DAILY_VOLUME | 2,748 shares | 800 | ▲ |
| CLOSE_PRICE | 20.88 INR | 19.9 | ▲ |
Cite this
Source: Samhati evidence synthesis for ROSELABS (2026-10-20). Observation: ROSELABS experienced a standard shift on 2026-10-20. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/roselabs
Filing step-changes